Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelegy Ellipta PIF Performance in COPD
NCT04606394Phase 4Completed
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone in chronic obstructive pulmonary disease (COPD). Started Dec 2020; status: completed.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04606394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04606394.